Asset Details
Do you wish to reserve the book?
Bilateral erector spinae plane block on opioid-sparing effect in upper abdominal surgery: study protocol for a bi-center prospective randomized controlled trial
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Bilateral erector spinae plane block on opioid-sparing effect in upper abdominal surgery: study protocol for a bi-center prospective randomized controlled trial
Do you wish to request the book?
Bilateral erector spinae plane block on opioid-sparing effect in upper abdominal surgery: study protocol for a bi-center prospective randomized controlled trial
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Bilateral erector spinae plane block on opioid-sparing effect in upper abdominal surgery: study protocol for a bi-center prospective randomized controlled trial
2024
Overview
Background
Erector spinae plane block (ESPB) is a promising technique for effective analgesia. It is still uncertain if ESPB offers the same opioid-sparing effect as thoracic paravertebral block (PVB) in midline incision for upper abdominal surgery.
Methods
The study is a prospective, bi-center, randomized, controlled, non-inferior trial. One hundred fifty-eight patients scheduled for upper abdominal surgery will be randomly assigned to receive bilateral ESPB or PVB before surgery. The primary outcome will be the equivalent cumulative analgesia dosage of sufentanil during the surgery, which is defined as the total dosage of sufentanil from anesthesia induction to tracheal extubation. The main secondary outcomes include postoperative complications and the quality of recovery-15 score at 24 h, 48 h, and 30 days after surgery.
Discussion
This study will assess the opioid-sparing efficacy of ESPB and PVB, complications, and the quality of recovery of two blocks.
Trial registration
ChiCTR2300073030 (
https://www.chictr.org.cn/
). Registered on 30 June 2023.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject
/ Adult
/ Aged
/ Analgesics, Opioid - administration & dosage
/ Analgesics, Opioid - therapeutic use
/ Female
/ Humans
/ Male
/ Medicine
/ Multicenter Studies as Topic
/ Pain, Postoperative - diagnosis
/ Pain, Postoperative - etiology
/ Pain, Postoperative - prevention & control
/ Paraspinal Muscles - innervation
/ Patients
/ Randomized Controlled Trials as Topic
/ Statistics for Life Sciences
/ Sufentanil - administration & dosage
/ Sufentanil - adverse effects
/ Surgery
